424 related articles for article (PubMed ID: 8678954)
1. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
2. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
[TBL] [Abstract][Full Text] [Related]
3. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.
Sugino K; Mimura T; Toshima K; Iwabuchi H; Kitamura Y; Kawano M; Ozaki O; Ito K
J Endocrinol Invest; 1993 Mar; 16(3):195-9. PubMed ID: 8099920
[TBL] [Abstract][Full Text] [Related]
4. Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Kure Y; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1995; 19(4):648-52. PubMed ID: 7676715
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
[TBL] [Abstract][Full Text] [Related]
6. [Long-term follow up after antithyroid drug treatment in Graves' disease].
Wille T; Müller B; Noth D; Bürgi U; Diem P
Praxis (Bern 1994); 2006 Jul; 95(29-30):1121-7. PubMed ID: 16916174
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum TSH receptor antibody (TRAb) values in patients with Graves' disease after total or subtotal thyroidectomy.
Takamura Y; Nakano K; Uruno T; Ito Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Kuma K; Miyauchi A
Endocr J; 2003 Oct; 50(5):595-601. PubMed ID: 14614216
[TBL] [Abstract][Full Text] [Related]
8. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
Miccoli P; Vitti P; Rago T; Iacconi P; Bartalena L; Bogazzi F; Fiore E; Valeriano R; Chiovato L; Rocchi R; Pinchera A
Surgery; 1996 Dec; 120(6):1020-4; discussion 1024-5. PubMed ID: 8957489
[TBL] [Abstract][Full Text] [Related]
10. Early hypothyroidism after subtotal thyroidectomy in patients with Graves' disease--the role of the preoperative conservative treatment and hormonal status.
Nonchev BI; Terzieva DD; Dimov RS; Mateva NG; Tsvetkova TZ; Dimitrakov DY
Folia Med (Plovdiv); 2005; 47(3-4):40-5. PubMed ID: 16761393
[TBL] [Abstract][Full Text] [Related]
11. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
[TBL] [Abstract][Full Text] [Related]
12. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
13. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of thyroidectomy for Graves' disease: A meta-analysis.
Palit TK; Miller CC; Miltenburg DM
J Surg Res; 2000 May; 90(2):161-5. PubMed ID: 10792958
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study.
Cappelli C; Gandossi E; Castellano M; Pizzocaro C; Agosti B; Delbarba A; Pirola I; De Martino E; Rosei EA
Endocr J; 2007 Dec; 54(5):713-20. PubMed ID: 17675761
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
Mori Y; Matoba N; Miura S; Sakai N; Taira Y
World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
[TBL] [Abstract][Full Text] [Related]
17. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
[TBL] [Abstract][Full Text] [Related]
18. Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication.
Smith J; Brown RS
Thyroid; 2007 Nov; 17(11):1103-7. PubMed ID: 17822376
[TBL] [Abstract][Full Text] [Related]
19. Surgery for Graves' disease: total versus subtotal thyroidectomy-results of a prospective randomized trial.
Witte J; Goretzki PE; Dotzenrath C; Simon D; Felis P; Neubauer M; Röher HD
World J Surg; 2000 Nov; 24(11):1303-11. PubMed ID: 11038198
[TBL] [Abstract][Full Text] [Related]
20. Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies.
Kawai K; Tamai H; Mori T; Morita T; Matsubayashi S; Katayama S; Kuma K; Kumagai LF
J Clin Endocrinol Metab; 1993 Sep; 77(3):716-9. PubMed ID: 7690362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
